References
- Blackwell B., Shepherd M. Prophylactic lithium: another therapeutic myth? An examination of the evidence to date. Lancet 1968; 1: 968
- Blackwell B. The drug defaulter. Clinical Pharmacology and Therapeutics 1972; 13: 841
- Blackwell B. Drug therapy: patient compliance. New England Journal of Medicine 1973; 259: 249
- Denham J., Adamson L. The contribution of fluphenazine enanthate and decanoate in the prevention of re-admission of schizophrenic patients. Acta Psychiatrica Scandinavica 1971; 47: 420
- Forrest I., Green D. E. Phenothiazines metabolism and analytic detection. Journal of Forensic Sciences 1972; 17: 592
- Hiep A. A viable programme for schizophrenic out-patients. Australian Nurses Journal 1975; 4: 29
- Hirsch S. R., Gaind R., Rohde P. D., Stevens B. C., Wing J. K. Out-patient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double blind placebo trial. British Medical Journal 1973; 1: 633
- Johnson D., Freeman H. Drug defaulting by patients on long-acting phenothiazines. Psychological Medicine 1973; 3: 115
- Krupinski J., Stoller A., Meridith E. Socio-psychiatric study of schizophrenia. Australian and New Zealand Journal of Psychiatry 1971; 5: 146
- Leff J., Wing J. Trial of maintenance therapy in schizophrenia. British Medical Journal 1971; 3: 559
- Marriott P., Grigor J., Hiep Z., Znaniecka V. A psychiatric clinic for depot phenothiazines. Medical Journal of Australia 1973; 2: 957
- Marriott P., Grigor J., Hiep A. Preliminary surveys (A). Modecate Newsletter, Royal Park 1974; 2: 16
- Marriott P., Grigor J., Hiep A. Flexibility in the use of fluphenazine decanoate. British Journal of Psychiatry 1975; 126: 204
- May P. Treatment of schizophrenia. I. A critique of reviews of the literature. Comprehensive Psychiatry 1974; 15: 179